Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2013 Oct 25;2(5):e000338. doi: 10.1161/JAHA.113.000338

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2013 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell.

This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

PMC Copyright notice

Figure 7. — Comparison of MLHFQ scores in POSEIDON and SCIPIO trials. A, POSEIDON trial showed improvement in MLHFQ score in the autologous MSC group at the 6‐ and 12‐month time points. B, SCIPIO trial demonstrated continuous improvement in MLHFQ score at 4 and 12 months. Panel A reproduced with permission from Hare et al, JAMA, 2012¹ and panel B from Chugh et al, Circulation, 2012.⁴ CSCs indicates cardiac stem cells; MLHFQ, Minnesota Living with Heart Failure Questionnaire; MSC, mesenchymal stem cell; POSEIDON, PercutaneOus StEm Cell Injection Delivery Effects On Neomyogenesis; SCIPIO, Stem Cell Infusion in Patients with Ischemic cardiomyopathy.